Login
$ZIVO
$3.60 -$0.35 (8.86%) Close

Ownership

13F as of Q2 2026 · 3.9M shares outstanding

Who owns ZIVO?

By type of holder
Institutions 0.0% Insiders 39.1% Everyone else 60.9%
Concentration Top 10 holders own 83.6%
Maggiore Christopher D. 13.4% · Hep Investments LLC 12.6%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Zivo Bioscience Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2024
+87.4%
+87.40% a year
Each share's claim on the business
−46.6%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $1.6M
over 2 fiscal years
Diluted shares, split-adjusted
1.6M2.4M3.2M2023: 1.7M shares'232024: 3.2M shares'24
Buybacks Stock-based comp
$0$755.5K$1.5M2023 buybacks: $02023 stock comp: $89.5K'232024 buybacks: $02024 stock comp: $1.5M'24

How patient are the owners?

No 13F manager reports holding ZIVO.

Super Investors

Investment managers reporting ZIVO on Form 13F
No 13F manager reports holding ZIVO yet.

Institutional Funds

Mutual funds and ETFs reporting ZIVO on Form N-PORT; together they hold 0.0% of the company
No fund reports holding ZIVO yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
MC
Maggiore Christopher D.
Insider
Shares
519.3K
% of company
13.35%
Change vs last qtr
—
Held since
—
HI
Hep Investments LLC
5%+ holder13D · 17.8%
Shares
488.8K
% of company
12.57%
Change vs last qtr
—
Held since
—

9 more holders behind a free account

See every insider and 5%+ holder of Zivo Bioscience Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support